Diagnostics, Vol. 15, Pages 1875: Synergistic Imaging: Combined Lung Ultrasound and Low-Dose Chest CT for Quantitative Assessment of COVID-19 Severity—A Prospective Observational Study


Diagnostics, Vol. 15, Pages 1875: Synergistic Imaging: Combined Lung Ultrasound and Low-Dose Chest CT for Quantitative Assessment of COVID-19 Severity—A Prospective Observational Study

Diagnostics doi: 10.3390/diagnostics15151875

Authors:
Andrzej Górecki
Piotr Piech
Karolina Kołodziejczyk
Ada Jankowska
Zuzanna Szostak
Anna Bronikowska
Bartosz Borowski
Grzegorz Staśkiewicz

Background/Objectives: To assess quantitatively the correlation between the lung ultrasound severity scores (LUSSs) and chest CT severity scores (CTSSs) derived from low-dose computed tomography (LDCT) for evaluating pulmonary inflammation in COVID-19 patients. Methods: In this prospective observational study, from an initial cohort of 1000 patients, 555 adults (≥18 years) with confirmed COVID-19 were enrolled based on inclusion criteria. All underwent LDCT imaging, scored by the CTSS (0–25 points), quantifying involvement across five lung lobes. Lung ultrasound examinations using standardized semi-quantitative scales for the B-line (LUSS B) and consolidation (LUSS C) were performed in a subgroup of 170 patients; 110 had follow-up imaging after one week. Correlation analyses included Spearman’s and Pearson’s coefficients. Results: Significant positive correlations were found between the CTSS and both the LUSS B (r = 0.32; p < 0.001) and LUSS C (r = 0.24; p = 0.006), with the LUSS B showing a slightly stronger relationship. Each incremental increase in the LUSS B corresponded to an average increase of 0.18 CTSS points, whereas a one-point increase in the LUSS C corresponded to a 0.27-point CTSS increase. The mean influence of the LUSS on CTSS was 8.0%. Neither ultrasound score significantly predicted ICU admission or mortality (p > 0.05). Conclusion: Standardized lung ultrasound severity scores show a significant correlation with low-dose CT in assessing pulmonary involvement in COVID-19, particularly for the B-line artifacts. Lung ultrasound represents a valuable bedside tool, complementing—but not substituting—CT in predicting clinical severity. Integrating both imaging modalities may enable the acquisition of complementary bedside information and facilitate dynamic monitoring of disease progression.



Source link

Andrzej Górecki www.mdpi.com